首页 | 本学科首页   官方微博 | 高级检索  
检索        

人纤溶酶原K5区基因真核表达载体的构建和活性鉴定
引用本文:杨健,王跃祥,官孝群,马春姑,陶贤梅,宋后燕.人纤溶酶原K5区基因真核表达载体的构建和活性鉴定[J].复旦学报(医学版),2003,30(5):409-413,F002.
作者姓名:杨健  王跃祥  官孝群  马春姑  陶贤梅  宋后燕
作者单位:复旦大学上海医学院细胞与遗传学系-教育部分子医学重点实验室,上海,200032
摘    要:目的 构建含人纤溶酶原K5区基因的真核表达载体,转染人乳腺癌细胞株MDA—MB—231,观察阳性克隆表达的K5蛋白对人脐静脉内皮细胞株ECV304和MDA—MB—231细胞增殖的影响。方法 应用PCR将人纤溶酶原信号肽序列引入K5cDNA,所得的目的片段与真核表达载体pcDNA3重组,构建重组质粒poDNA3K5,脂质体法将其转染MDA—MB—231,G418筛选阳性克隆,PCR鉴定,RT-PCR和Western blot检测K5的表达。将鉴定正确的阳性克隆的培养上清作用于ECV304细胞,MTT、法检测其增殖情况,并用MTT法检测转染pcDNA3K5对MDA—MB—231细胞增殖的影响。结果 构建的重组质粒pcDNA3K5经酶切鉴定、测序正确,将其转染MDA-MB-231后挑取的阳性克隆有3个经PCR鉴定正确,并经RT-PCR和Western blot检测证实K5的表达。阳性克隆的培养上清作用于ECV304细胞后,其存活率降低;转染pcDNA3K5对MDA—MB—231细胞增殖无明显影响。结论 应用脂质体法将带有人纤溶酶原信号肽序列的K5cDNA转染MDA-MB-231细胞后,其分泌产生的有生物学活性的K5,呈现对ECV304细胞增殖的抑制作用,而对MDA-MB-231细胞的生长则无影响。

关 键 词:乳腺癌  基因治疗  重组新生血管生成抑制因子K5  基因表达  真核表达载体  构建  活性鉴定

Human Plasminogen Kringle 5 cDNA Clone with Eukaryotic System and Identification of Its Expression Product
YANG Jian,WANG Yue-xiang,GUAN Xiao-qun,MA Chun-gu,TAO Xian-mei,SONG Hou-yan.Human Plasminogen Kringle 5 cDNA Clone with Eukaryotic System and Identification of Its Expression Product[J].Fudan University Journal of Medical Sciences,2003,30(5):409-413,F002.
Authors:YANG Jian  WANG Yue-xiang  GUAN Xiao-qun  MA Chun-gu  TAO Xian-mei  SONG Hou-yan
Abstract:Purpose To construct eukaryotic expression vector coding human plasminogen kringle 5 cDNA and investigate its inhibitory effects on human umbilical vein endothelial cell line(ECV304) as well as human breast adenocarcinoma cell line(MDA?MB?231) by liposome-mediated gene transfer. Methods The K5 cDNA was fused in-frame with human plasminogen signal sequence by PCR and it was inserted into an eukaryotic expression vector pcDNA3,the recombinant plasmid named pcDNA3K5 was assayed by restriction endonucleases and sequenced.Subconfluent human breast carcinoma cells (MDA?MB?231) were transfected with pcDNA3K5 and pcDNA3 by liposome method.Transfected cells were selected at 1 mg/mL G418 in DMEM containing 10%FBS for 2 weeks.Single cell clones were picked and expanded in the pre-sence of G418.The positive clones were verified by PCR.The expression of K5 mRNA and protein was assayed by RT-PCR and Western blot.The 72 h conditioned media of the positive clones were applied to ECV304 testing their antiproliferation effects and assayed by MTT.The proliferation of pcDNA3K5 transfected MDA?MB?231 was also assayed by MTT. Results The recombinant plasmid pcDNA3K5 was verified by restriction endonuclease analysis and sequencing.After it was transfected into MDA?MB?231,three positive clones were verified by PCR.RT?PCR and Western blot detected the expression of K5 mRNA and protein.The conditioned media of the positive clones inhibited the proliferation of ECV304.In contrast,the proliferation of pcDNA3K5 transfected MDA?MB?231 was not affected. Conclusions The biologically active K5 secreted by pcDNA3K5 transfected MDA?MB?231 showed inhibitory effects on the proliferation of ECV304 but had no effects on the proliferation of MDA?MB?231.
Keywords:recombinant angiogenic inhibitor K5  breast cancer  gene therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号